About NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes is a company based in Madison (United States) founded in 2006.. NorthStar Medical Radioisotopes has raised $15.09 million across 13 funding rounds from investors including DOE, Oberland Capital and Hendricks Holding. NorthStar Medical Radioisotopes offers products and services including Actinium-225, Copper-67, and CDMO/CMO Services. NorthStar Medical Radioisotopes operates in a competitive market with competitors including ARTMS, Niowave, Nanovista, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Northstar Medical Radioisotopes, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.09 M (USD)
in 13 rounds
-
Latest Funding Round
$15 M (USD), Grant
Jul 23, 2019
-
Investors
DOE
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes offers a comprehensive portfolio of products and services, including Actinium-225, Copper-67, and CDMO/CMO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Isotope produced for targeted cancer therapy applications.
Isotope used in treatments for cancer and other diseases.
Provides development and manufacturing for radiopharmaceutical products.
Unlock access to complete
Funding Insights of NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes has successfully raised a total of $15.09M across 13 strategic funding rounds. The most recent funding activity was a Grant round of $15 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Grant — $15.0M
-
First Round
First Round
(11 Mar 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Grant - NorthStar Medical Radioisotopes | Valuation |
investors |
|
| Apr, 2019 | Amount | Debt – Conventional - NorthStar Medical Radioisotopes | Valuation |
investors |
|
| Oct, 2015 | Amount | Grant - NorthStar Medical Radioisotopes | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include DOE, Oberland Capital and Hendricks Holding. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment capital is provided to early-stage technology companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NorthStar Medical Radioisotopes
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NorthStar Medical Radioisotopes
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Northstar Medical Radioisotopes Comparisons
Competitors of NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, Niowave, Nanovista, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| domain | founded_year | HQ Location |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| domain | founded_year | HQ Location |
Multimodal visualization agents are developed for image-guided interventions.
|
|
| domain | founded_year | HQ Location |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| domain | founded_year | HQ Location |
Limited information available
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Northstar Medical Radioisotopes
Frequently Asked Questions about NorthStar Medical Radioisotopes
When was NorthStar Medical Radioisotopes founded?
NorthStar Medical Radioisotopes was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Where is NorthStar Medical Radioisotopes located?
NorthStar Medical Radioisotopes is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Is NorthStar Medical Radioisotopes a funded company?
NorthStar Medical Radioisotopes is a funded company, having raised a total of $15.09M across 13 funding rounds to date. The company's 1st funding round was a Grant of $11.75M, raised on Mar 11, 2010.
What does NorthStar Medical Radioisotopes do?
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.
Who are the top competitors of NorthStar Medical Radioisotopes?
NorthStar Medical Radioisotopes's top competitors include ARTMS, Niowave and ATOMIC ALCHEMY.
What products or services does NorthStar Medical Radioisotopes offer?
NorthStar Medical Radioisotopes offers Actinium-225, Copper-67, and CDMO/CMO Services.
Who are NorthStar Medical Radioisotopes's investors?
NorthStar Medical Radioisotopes has 5 investors. Key investors include DOE, Oberland Capital, Hendricks Holding, Stateline Angels, and OSTI.GOV.